146 related articles for article (PubMed ID: 6441061)
1. [Lipids and apoproteins A1 and B in patients with ischemic heart disease with stenosing atherosclerosis of the coronary arteries and the abdominal aorta].
Kurdanov KhA; Perova NV; Polesskiĭ VA; Agapov AA; Metel'skaia VA
Kardiologiia; 1984 Oct; 24(10):84-7. PubMed ID: 6441061
[TBL] [Abstract][Full Text] [Related]
2. Atherogenicity of blood serum from patients with coronary heart disease.
Chazov EI; Tertov VV; Orekhov AN; Lyakishev AA; Perova NV; Kurdanov KA; Khashimov KA; Novikov ID; Smirnov VN
Lancet; 1986 Sep; 2(8507):595-8. PubMed ID: 2875319
[TBL] [Abstract][Full Text] [Related]
3. Sex hormones, lipids, lipoprotein cholesterols, and apolipoproteins in normal and obese subjects: atherogenic relationships.
Mendoza SG; Zerpa A; Velazquez E; Schwarzenberg A; Hynd B; Kashyap ML; Laskarzewski P; Glueck CJ
Int J Obes; 1986; 10(6):427-41. PubMed ID: 3100468
[TBL] [Abstract][Full Text] [Related]
4. [Serum apolipoproteins A-1 and B in young males with a history of myocardial infarction].
Vetrov AV; Metel'skaia VA; Gerasimova EN; Barats SS; Perova NV
Kardiologiia; 1984 Oct; 24(10):87-90. PubMed ID: 6441062
[TBL] [Abstract][Full Text] [Related]
5. Discriminative value of lipids and apoproteins in coronary heart disease.
De Backer G; Rosseneu M; Deslypere JP
Atherosclerosis; 1982 Apr; 42(2-3):197-203. PubMed ID: 6803813
[TBL] [Abstract][Full Text] [Related]
6. Levels of serum lipids, apolipoproteins A-I and B and pseudocholinesterase activity and their discriminative values in patients with coronary by-pass operation.
Lehtonen A; Marniemi J; Inberg M; Maatela J; Alanen E; Niittymäki K
Atherosclerosis; 1986 Feb; 59(2):215-21. PubMed ID: 3083832
[TBL] [Abstract][Full Text] [Related]
7. [Serum lipids and apolipoproteins AI, B100, CI, CII, and CIII in 142 patients with coronary heart disease].
Liu BW; Shao MZ; Yuan HJ; Wu ZF; Zhang ZH; Fu MD; Zhang RJ; Fan P
Hua Xi Yi Ke Da Xue Xue Bao; 1989 Jun; 20(2):119-22. PubMed ID: 2512245
[TBL] [Abstract][Full Text] [Related]
8. [Change in the spectrum of lipids and apoproteins A1 and B as affected by hypothiazide and pratsiol in patients with hypertension].
Oganov RG; Mustafaev II; Perova NV; Postol'nikov SF; Metel'skaia VA
Kardiologiia; 1985 Aug; 25(8):17-22. PubMed ID: 4068453
[TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of apolipoprotein B and AI determinations in coronary heart disease].
Li JZ; Wang JJ; Niu QT
Zhonghua Nei Ke Za Zhi; 1989 Jun; 28(6):351-5, 381-2. PubMed ID: 2510981
[TBL] [Abstract][Full Text] [Related]
10. Are apolipoproteins A and B better than lipoproteins for assessing risk of obstructive coronary heart disease?
Manfroi WC; Zago AJ; Campos M; Alves A; Brisolara ML; de Souza J; Candiago RH; Kirschnick L; Ribeiro L; Ordovás K; Leitão C; Cruz R
Arq Bras Cardiol; 1999 Jun; 72(6):657-68. PubMed ID: 10752172
[TBL] [Abstract][Full Text] [Related]
11. MspI polymorphism at +83 bp in intron 1 of the human apolipoprotein A1 gene is associated with elevated levels of HDL cholesterol and apolipoprotein A1 in nondiabetic subjects but not in type 2 diabetic patients with coronary heart disease.
Pulkkinen A; Viitanen L; Kareinen A; Lehto S; Laakso M
Diabetes Care; 2000 Jun; 23(6):791-5. PubMed ID: 10840998
[TBL] [Abstract][Full Text] [Related]
12. [Plasma lipoproteins and apolipoproteins. Value of their determination in the detection of coronary atherosclerosis. Comparison with data supplied by coronarography].
Fruchart JC; Bertrand M; Parra H; Gentilini JL; Boniface B; Boniface M
Nouv Presse Med; 1982 Nov; 11(47):3491-4. PubMed ID: 6818524
[TBL] [Abstract][Full Text] [Related]
13. Is the ratio of apo B/apo A-I an early predictor of coronary atherosclerosis?
Van Stiphout WA; Hofman A; Kruijssen HA; Vermeeren R; Groot PH
Atherosclerosis; 1986 Nov; 62(2):179-82. PubMed ID: 3099804
[TBL] [Abstract][Full Text] [Related]
14. [Physical exercise and atherosclerosis: proatherogenic effects of high and moderate intensity static exercise on blood lipid transport system].
Aronov DM; Bubnova MG; Perova NV; Bondarenko IZ; Olfer'ev AM
Kardiologiia; 2003; 43(2):35-9. PubMed ID: 12891270
[TBL] [Abstract][Full Text] [Related]
15. Comparison of children and coronary heart disease patients with low high density lipoprotein cholesterol levels.
Ohta T; Saku K; Nakamura R; Maung KK; Matsuda I
Atherosclerosis; 1998 Apr; 137(2):321-8. PubMed ID: 9622275
[TBL] [Abstract][Full Text] [Related]
16. Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes.
Berneis K; Jeanneret C; Muser J; Felix B; Miserez AR
Metabolism; 2005 Feb; 54(2):227-34. PubMed ID: 15690318
[TBL] [Abstract][Full Text] [Related]
17. Atherosclerosis precursors in Finnish children and adolescents. VI. Serum apolipoproteins A-I and B.
Solakivi-Jaakkola T; Nikkari T; Viikari J; Akerblom HK; Räsänen L; Uhari M; Dahl M; Lähde PL; Pesonen E; Pietikäinen M
Acta Paediatr Scand Suppl; 1985; 318():119-25. PubMed ID: 3937432
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of apolipoproteins A-I and B as markers of angiographically assessed coronary artery disease.
Marcovina S; Zoppo A; Graziani MS; Vassanelli C; Catapano AL
Ric Clin Lab; 1988; 18(4):319-28. PubMed ID: 3150125
[TBL] [Abstract][Full Text] [Related]
19. Serum elastase-type enzymes and their correlation to blood lipids in male patients with atherosclerosis.
Landi A; Bihari-Varga M; Keller L
Acta Med Hung; 1991; 48(3-4):203-10. PubMed ID: 1822858
[TBL] [Abstract][Full Text] [Related]
20. Apolipoproteins C-II and C-III in peripheral arterial disease.
Alessandri C; Basili S; Maurelli M; Andreozzi P; Colletta A; Paradiso M; Cordova C
Angiology; 1994 Feb; 45(2):131-6. PubMed ID: 8129188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
